Virax Biolabs Group Limited's ROA from the fourth quarter of 2024 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Virax Biolabs Group Limited's ROA in the fourth quarter of 2024?

However, within the Healthcare sector 842 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from to 4811.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter
Y / Y Total Assets Change	-34.77 %	-48.69 %	3219.14 %	1053.47 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	0	0	0
Return On Assets (TTM)	0 %	0 %	0 %	0 %	0 %
VRAX's Total Ranking	# 4811	#	#	#	# 4814
Total Assets (TTM) in million	7	5	20	5	11
Seq. Total Assets Change	24.92 %	-73.02 %	270.59 %	-47.78 %	-1.75 %
Seq. Net Income Change	-	-	-	-	-

VRAX's 5 Years Annual ROA >> Back to VRAX Management Effectiveness >> Compare VRAX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 13
Sector	# 843
Overall	# 4612

Return On Assets Statistics
High	Average	Low
-55.62 %	-90.97 %	-122.89 %
(Mar 31 2023)		(Mar 31 2024)

Financial Statements
Virax Biolabs Group Limited's Assets	$ 7 million	VRAX's Balance sheet
Virax Biolabs Group Limited's Income	$ 0 million	Quarterly VRAX's Income Statement
VRAX's Income by Division		See VRAX's Income by Division

Annual Return On Assets	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2021) FY 2022	FY
Y / Y Total Assets Change	-34.77 %	-48.33 %	3214.26 %	-	-
Total Assets in million	7	11	20	1	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-6	-7	-5	-2	0
Annual Return On Assets	-88.56 %	-64.17 %	-26.86 %	-285.37 %	-

VRAX's 5 Years Annual ROA >> Back to VRAX Management Effectiveness >> Compare VRAX ROA to its Competitors

More Return On Assets Ratios
VRAX's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VRAX's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VRAX's Competitors
Subscribers only: Roa for Virax Biolabs Group Limited's Suppliers
Subscribers only: Return On Assets for VRAX's Customers

You may also want to know
VRAX's Roi	VRAX's Inventory Turnover Ratio	VRAX's Growth Rates	VRAX's Dividend Comparisons
	VRAX's Profitability Ratios	VRAX's Asset Turnover Ratio	VRAX's Dividend Growth
VRAX's Roe	VRAX's Valuation Ratios	VRAX's Financial Strength Ratios	VRAX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector

ROA

Date modified: 2024-10-22T17:06:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.